Trial intelligence / Profile preview

Rivastigmine in Vascular Cognitive Impairment Not Dementia

NCT00669344Phase 4Completed

Sponsor
Singapore General Hospital
Start
Feb 2006
Primary completion
Apr 2007
Modality
Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of rivastigmine in vascular cognitive impairment (VCI), sponsored by Singapore General Hospital. Started Feb 2006; status: completed.

02

Drugs

rivastigmine
03

Conditions

vascular cognitive impairment (VCI)

Beyond the preview

Go deeper on NCT00669344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00669344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call